The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
Open accessAbstract
Extensive research causally links amyloid-beta peptide (A beta) to Alzheimer's disease, although the pathologically relevant A beta conformation remains unclear. A beta spontaneously aggregates into the fibrils that deposit in senile plaques. However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A beta. To consistently prepare in vitro oligomeric and fibrillar forms of A beta 1-42, a detailed knowledge of how solution parameters influence structure is required. This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A beta species. We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta 1-42-induced neurotoxicity significant at 10 nm. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A beta1-42 from isoforms containing familial mutations (Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) J. Biol. Chem. 277, 32046-32053). Understanding the biological role of specific A beta conformations may define the link between A beta and Alzheimer's disease, re-focusing therapeutic approaches by identifying the pernicious species of A beta ultimately responsible for the cognitive dysfunction that defines the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, the MOAB-2-based oA42 ELISA detects oligomeric but not monomeric A42 using synthetic preparations characterized previously by our laboratory (data not shown) (47,48).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Research works printed but not linked: 3
- Hou, 2002, J. Biol. Chem., 26, 26
- DePace, 2002, Nat. Struct. Biol., 9, 389
- Fezoui, 2002, J. Biol. Chem., 30, 30
Cited by
Sorted by citations
Items 401–500 of 999
Li, H., Du, Z., Lopes, D. H. J., Fradinger, E. A., Wang, C., & Bitan, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200982p · Cited by 43
McIntee, F. L., Giannoni, P., Blais, S. P., Sommer, G., Neubert, T. A., Rostagno, A. A., & Ghiso, J. A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00223 · Cited by 42
Jha, A., Ghormade, V., Kolge, H., & Paknikar, K. M. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00162j · Cited by 42
Specific Domains of Aβ Facilitate Aggregation on and Association with Lipid Bilayers
Yates, E. A., Owens, S. L., Lynch, M. F., Cucco, E. M., Umbaugh, C. S., & Legleiter, J. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.022 · Cited by 41
Controlling Amyloid‐β Peptide(1–42) Oligomerization and Toxicity by Fluorinated Nanoparticles
Saraiva, A. M., Cardoso, I., Pereira, M. D. C., Coelho, M. A. N., Saraiva, M. J., Möhwald, H., & Brezesinski, G. (2010) · ChemBioChem · doi:10.1002/cbic.201000237 · Cited by 41
Bros, P., Delatour, V., Vialaret, J., Lalère, B., Barthélemy, N. R., Gabelle, A., Lehmann, S., & Hirtz, C. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1048 · Cited by 41
Solomonov, I., Korkotian, E., Born, B., Feldman, Y., Bitler, A., Rahimi, F., Li, H., Bitan, G., & Sagi, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344036 · Cited by 41
Cieślik, M., Czapski, G. A., & Strosznajder, J. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137193 · Cited by 43
Jia, S., Wu, X., Li, X., Dai, X., Gao, Z., Zheng, L., Zheng, Q., & Sun, Y. (2016) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2016.1201811 · Cited by 41
Wang, L., Zeng, R., Pang, X., Gu, Q., & Tan, W. (2015) · RSC Advances · doi:10.1039/c5ra12328c · Cited by 40
Salins, P. B., He, Y., Olson, K. L., Glazner, G. W., Kashour, T. S., & Amara, F. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.025 · Cited by 41
Murakami, K., Hara, H., Masuda, Y., Ohigashi, H., & Irie, K. (2007) · ChemBioChem · doi:10.1002/cbic.200700240 · Cited by 40
Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain
Sarkar, P., Narayanan, J., & Harder, D. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.058 · Cited by 42
Kim, Y. A., Siddiqui, T., Blaze, J., Coşacak, M. İ., Winters, T., Kumar, A., Tein, E., Sproul, A. A., Teich, A. F., Bartolini, F., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02511-7 · Cited by 44
A Universal Method for Detection of Amyloidogenic Misfolded Proteins
Yam, A. Y.-W., Wang, X., Gao, C. M., Connolly, M. D., Zuckermann, R. N., Bleu, T., Hall, J., Fedynyshyn, J. P., Allauzen, S., Peretz, D., et al. (2011) · Biochemistry · doi:10.1021/bi200215j · Cited by 39
Chauhan, M., Modi, P. K., & Sharma, P. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2647-1 · Cited by 40
An update on the toxicity of Aβ in Alzheimer’s disease
Götz, J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3016 · Cited by 40
Carriba, P., Jiménez, S., Navarro, V., Moreno‐González, I., Barneda‐Zahonero, B., Moubarak, R. S., López‐Soriano, J., Gutiérrez, A., Vitórica, J., & Comella, J. X. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.6 · Cited by 40
An Azobenzene Photoswitch Sheds Light on Turn Nucleation in Amyloid-β Self-Assembly
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn2001188 · Cited by 40
Yue, F., Feng, S., Lu, C., Zhang, T., Tao, G., Liu, J., Yue, C., & Jing, N. (2021) · iScience · doi:10.1016/j.isci.2021.103207 · Cited by 41
Greven, J. A., Wydra, J. R., Greer, R. A., Zhi, C., Price, D. A., Svoboda, J. D., Camitta, C. L. M., Washington, M., Leung, D. W., Song, Y., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00795-9 · Cited by 42
Taniguchi, A., Skwarczyński, M., Sohma, Y., Okada, T., Ikeda, K., Prakash, H., Mukai, H., Hayashi, Y., Kimura, T., Hirota, S., et al. (2008) · ChemBioChem · doi:10.1002/cbic.200800503 · Cited by 39
Aβ peptide conformation determines uptake and interleukin-1α expression by primary microglial cells
Parvathy, S., Rajadas, J., Ryan, H. S., Vaziri, S., Anderson, L., & Murphy, G. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.011 · Cited by 39
Amyloid β Fibril Elongation by Monomers Involves Disorder at the Tip
Bacci, M., Vymětal, J., Mihajlovic, M., Caflisch, A., & Vitalis, A. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00662 · Cited by 39
TGF-β1 protection against Aβ1–42-induced hippocampal neuronal inflammation and apoptosis by TβR-I
Fang, X.-X., Sun, G.-L., Zhou, Y., Qiu, Y., & Peng, Y.-P. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000940 · Cited by 39
Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity
Ippati, S., Deng, Y., van der Hoven, J., Heu, C., van Hummel, A., Chua, S. W., Parić, E., Chan, G., Feiten, A., Fath, T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011876118 · Cited by 39
Rapid Assembly of Amyloid-β Peptide at a Liquid/Liquid Interface Produces Unstable β-Sheet Fibers
Nichols, M. R., Moss, M. A., Reed, D. K., Hoh, J. H., & Rosenberry, T. L. (2004) · Biochemistry · doi:10.1021/bi048846t · Cited by 39
Fernàndez‐Busquets, X., Ponce, J., Bravo, R., Arimon, M., Martiáñez, T., Gella, A., Cladera, J., & Durany, N. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383787 · Cited by 38
Li, M., Pisalyaput, K., Galvan, M. D., & Tenner, A. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02765.x · Cited by 38
Novel curcumin derivatives as potent inhibitors of amyloid β aggregation
Yanagisawa, D., Taguchi, H., Morikawa, S., Kato, T., Hirao, K., Shirai, N., & Tooyama, I. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.10.009 · Cited by 38
Brown, A. M., Lemkul, J. A., Schaum, N., & Bevan, D. R. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.01.002 · Cited by 39
Sadleir, K. R., Eimer, W. A., Kaufman, R. J., Osten, P., & Vassar, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101643 · Cited by 40
Wang, L.-S., Xue, T., Liu, X., Zhou, Y., Zhang, M.-D., Liao, Y., Pan, R., & Chang, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01084 · Cited by 38
Rolland, M., Powell, R., Jacquier‐Sarlin, M. R., Boisseau, S., Reynaud-Dulaurier, R., Hernández, J. M., André, L., Borel, E., Buisson, A., & Lanté, F. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2501-19.2020 · Cited by 41
Gao, Y., Guo, C., Watzlawik, J. O., Randolph, P. S., Lee, E. J., Huang, D., Stagg, S. M., Zhou, H., Rosenberry, T. L., & Paravastu, A. K. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.05.018 · Cited by 38
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Lacor, P. N. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 40
Sinopoli, A., Giuffrida, A., Tomasello, M. F., Giuffrida, M. L., Leone, M., Attanasio, F., Caraci, F., Bona, P. D., Николаевна, Н. И., Saviano, M., et al. (2016) · ChemBioChem · doi:10.1002/cbic.201600243 · Cited by 38
In vitroOligomerization and Fibrillogenesis of Amyloid-beta Peptides
Benseny‐Cases, N., Klementieva, O., & Cladera, J. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_3 · Cited by 39
Roselli, F., Livrea, P., & Almeida, O. F. X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023097 · Cited by 38
Overcoming synthetic Aβ peptide aging: a new approach to an age-old problem
Manzoni, C., Colombo, L., Messa, M., Cagnotto, A., Cantú, L., Favero, E. D., & Salmona, M. (2009) · Amyloid · doi:10.1080/13506120902879848 · Cited by 37
Lynx1 and Aβ1–42 bind competitively to multiple nicotinic acetylcholine receptor subtypes
Thomsen, M. S., Arvaniti, M., Jensen, M. M., Shulepko, M. A., Dolgikh, D. A., Pinborg, L. H., Härtig, W., Lyukmanova, E. N., & Mikkelsen, J. D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.009 · Cited by 37
Mrđenović, D., Majewska, M., Pieta, I. S., Bernatowicz, P., Nowakowski, R., Kutner, W., Lipkowski, J., & Pięta, P. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b01645 · Cited by 39
Rofo, F., Meier, S. R., Metzendorf, N. G., Morrison, J. I., Petrovic, A., Syvänen, S., Sehlin, D., & Hultqvist, G. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01283-y · Cited by 41
Stravalaci, M., Beeg, M., Salmona, M., & Gobbi, M. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.10.038 · Cited by 36
‘O-Acyl isopeptide method’ for the efficient preparation of amyloid β peptide 1–42 mutants
Sohma, Y., Chiyomori, Y., Kimura, M., Fukao, F., Taniguchi, A., Hayashi, Y., Kimura, T., & Kiso, Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.037 · Cited by 38
Effects of Amyloid β-Peptides on the Lysis Tension of Lipid Bilayer Vesicles Containing Oxysterols
Kim, D. H., & Frangos, J. A. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.114983 · Cited by 37
LPYFDa Neutralizes Amyloid-β-Induced Memory Impairment and Toxicity
Granic, I., Masman, M. F., Mulder, C. K., Nijholt, I. M., Naudé, P., de Haan, A., Borbély, E., Penke, B., Luiten, P. G. M., & Eisel, U. L. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1297 · Cited by 37
Tiiman, A., Noormägi, A., Friedemann, M., Krishtal, J., Palumaa, P., & Tõugu, V. (2013) · Journal of Peptide Science · doi:10.1002/psc.2513 · Cited by 36
Granic, I., Nyakas, C. J., Luiten, P. G. M., Eisel, U. L. M., Halmy, L. G., Groß, G., Schoemaker, H., Möller, A., & Nimmrich, V. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.013 · Cited by 36
An integrated strategy to correlate aggregation state, structure and toxicity of Aß 1–42 oligomers
Bisceglia, F., Natalello, A., Serafini, M. M., Colombo, R., Verga, L., Lanni, C., & Lorenzi, E. D. (2018) · Talanta · doi:10.1016/j.talanta.2018.05.062 · Cited by 37
Immunosenescence as a convergence pathway in neurodegeneration
Mohapatra, L., Mishra, D. K., Tripathi, A. S., & Parida, S. K. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110521 · Cited by 38
Bhattacharjee, S., Zhao, Y., & Lukiw, W. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00116 · Cited by 34
H2O2 and PAF mediate Aβ1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761
Shi, C., Wu, F., & Xu, J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.016 · Cited by 35
Wang, X., Li, L., Gu, X., Yu, B., & Jiang, M. (2021) · Microchimica Acta · doi:10.1007/s00604-021-04704-5 · Cited by 35
Matuszyk, M. M., Garwood, C. J., Ferraiuolo, L., Simpson, J. E., Staniforth, R. A., & Wharton, S. B. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15538 · Cited by 37
Hexafluoroisopropanol induces self‐assembly of β‐amyloid peptides into highly ordered nanostructures
Pachahara, S. K., Chaudhary, N., Subbalakshmi, C., & Nagaraj, R. (2012) · Journal of Peptide Science · doi:10.1002/psc.2391 · Cited by 33
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1–42
Janíčková, H., Rudajev, V., Zimčík, P., Jakubík, J., Tanila, H., El‐Fakahany, E. E., & Doležal, V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.014 · Cited by 37
Saraiva, A. M., Cardoso, I., Saraiva, M. J., Tauer, K., Pereira, M. D. C., Coelho, M. A. N., Möhwald, H., & Brezesinski, G. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900448 · Cited by 36
Circular dichroism and aggregation studies of amyloid beta (11-8) fragment and its variants.
Juszczyk, P., Kołodziejczyk, A. S., & Grzonka, Z. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3455 · Cited by 40
van Gijsel‐Bonnello, M., Baranger, K., Benech, P., Rivera, S., Khrestchatisky, M., Reggi, M. L. D., & Gharib, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194586 · Cited by 35
Rauth, S., Hinz, D., Borger, M. A., Uhrig, M., Mayhaus, M., Riemenschneider, M. J., & Skerra, A. (2016) · Biochemical Journal · doi:10.1042/bcj20160114 · Cited by 35
Detection of amyloid β oligomers toward early diagnosis of Alzheimer's disease
Hwang, S., Chan, H. K., Sorci, M., Deventer, J. A. V., Wittrup, K. D., Belfort, G., & Walt, D. R. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.09.011 · Cited by 36
Pradier, L., Blanchard-Brégeon, V., Bohme, A., Debeir, T., Ménager, J., Benoit, P., Barnéoud, P., Taupin, V., Bertrand, P., Dugay, P., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0447-y · Cited by 37
Sun, J. L., Stokoe, S. A., Roberts, J. P., Sathler, M. F., Nip, K., Shou, J., Ko, K. H., Tsunoda, S., & Kim, S. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.005 · Cited by 36
Effects of Aβ-derived peptide fragments on fibrillogenesis of Aβ
Abedin, F., Kandel, N., & Tatulian, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-98644-y · Cited by 34
Zhang, L., Yagnik, G. B., Peng, Y., Wang, J., Xu, H. H., Hao, Y., Liu, Y., & Zhou, F. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.11.025 · Cited by 34
Izuo, N., Kume, T., Sato, M., Murakami, K., Irie, K., Izumi, Y., & Akaike, A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300033k · Cited by 34
Myelin Basic Protein Binds to and Inhibits the Fibrillar Assembly of Aβ42 in Vitro
Hoos, M. D., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2009) · Biochemistry · doi:10.1021/bi900037s · Cited by 37
Ferrera, D., Mazzaro, N., Canale, C., & Gasparini, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.023 · Cited by 33
Czapski, G. A., Cieślik, M., Wencel, P. L., Wójtowicz, S., Strosznajder, R. P., & Strosznajder, J. B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.11.003 · Cited by 33
Wang, Y., Zhang, G., Zhou, H., Barakat, A., & Querfurth, H. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008366 · Cited by 34
Interaction between Prion Protein and Aβ Amyloid Fibrils Revisited
Nieznański, K., Surewicz, K. A., Chen, S., Nieznańska, H., & Surewicz, W. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500019c · Cited by 33
Proteolytic Antibody Light Chains Alter β-Amyloid Aggregation and Prevent Cytotoxicity
Liu, R., McAllister, C., Lyubchenko, Y. L., & Sierks, M. R. (2004) · Biochemistry · doi:10.1021/bi0492354 · Cited by 34
Turn Nucleation Perturbs Amyloid β Self-Assembly and Cytotoxicity
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.055 · Cited by 32
Sharma, B., Kalita, S., Paul, A., Mandal, B., & Paul, S. (2016) · RSC Advances · doi:10.1039/c6ra17602j · Cited by 32
Lipid microdomain modification sustains neuronal viability in models of Alzheimer’s disease
Herzer, S., Meldner, S., Rehder, K. F., Gröne, H., & Nordström, V. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0354-z · Cited by 33
Wang, X., Kastanenka, K. V., Arbel‐Ornath, M., Commins, C., Kuzuya, A., Lariviere, A., Krafft, G. A., Hefti, F. F., Jerecìć, J., & Bacskai, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22979-2 · Cited by 32
Self-citationKeto form of curcumin derivatives strongly binds to Aβ oligomers but not fibrils
Yanagisawa, D., Kato, T., Taguchi, H., Shirai, N., Hirao, K., Sogabe, T., Tomiyama, T., Gamo, K., Hirahara, Y., Kitada, M., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120686 · Cited by 32
A New Method to Measure Cellular Toxicity of Non-Fibrillar and Fibrillar Alzheimer's Aβ Using Yeast
Bharadwaj, P., Waddington, L. J., Varghese, J. N., & Macreadie, I. G. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13204 · Cited by 34
Michaud, J.-P., Richard, K. L., & Rivest, S. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9356-9 · Cited by 32
TrkA pathway activation induced by amyloid-beta (Abeta)
Bulbarelli, A., Lonati, E., Cazzaniga, E., Re, F., Sesana, S., Barisani, D., Sancini, G., Mutoh, T., & Masserini, M. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.12.006 · Cited by 32
Shigemitsu, Y., & Hiroaki, H. (2017) · The Journal of Biochemistry · doi:10.1093/jb/mvx056 · Cited by 34
Overview on Rodent Models of Alzheimer's Disease
Dodart, J., & May, P. C. (2005) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0922s33 · Cited by 32
Ramberg, V., Tracy, L. M., Samuelsson, M., Nilsson, L. N. G., & Iverfeldt, K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-34 · Cited by 33
Alier, K. A., Ma, L., Yang, J., Westaway, D. A., & Jhamandas, J. H. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4367-11.2011 · Cited by 30
Cernescu, M., Stark, T., Kalden, E., Kurz, C., Leuner, K., Deller, T., Göbel, M., Eckert, G. P., & Brutschy, B. (2012) · Analytical Chemistry · doi:10.1021/ac300258m · Cited by 30
Herrera, M. G., Castro, M. F. G., Prieto, E. D., Barrera, E., Dodero, V. I., Pantano, S., & Chirdo, F. G. (2019) · FEBS Journal · doi:10.1111/febs.15109 · Cited by 31
Qi, W., Zhang, A., Patel, D. A., Lee, S., Harrington, J. L., Zhao, L., Schaefer, D., Good, T. A., & Fernández, E. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21846 · Cited by 31
Amyloid-β fibril formation is not necessarily required for microglial activation by the peptides
Hashioka, S., Monji, A., Ueda, T., Kanba, S., & Nakanishi, H. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.05.001 · Cited by 30
Song, X., Hu, J., Sun, M., Li, Z. P., Wu, D. H., Ji, H.-L., Yuan, Y., Zhu, Z., Han, N., Liu, G., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.049 · Cited by 30
Controlled aggregation of peptide–DNA hybrids into amyloid-like fibrils
Abraham, J. N., Gour, N., Bolisetty, S., Mezzenga, R., & Nardin, C. (2015) · European Polymer Journal · doi:10.1016/j.eurpolymj.2015.02.009 · Cited by 30
Ha, C., & Park, C. B. (2006) · Langmuir · doi:10.1021/la0601511 · Cited by 30
Hierarchical and ultra-sensitive amyloid beta oligomer sensor for practical applications
Qin, J., Kim, S., Cho, M., & Lee, Y. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126055 · Cited by 31
Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells
Jang, S., Chapa‐Dubocq, X. R., Parodi‐Rullán, R. M., Fossati, S., & Javadov, S. A. (2022) · Cells · doi:10.3390/cells11030373 · Cited by 30
Amyloid beta1-42 peptide regulates microtubule stability independently of tau
Pianu, B., Lefort, R., Thuiliere, L., Tabourier, E., & Bartolini, F. (2014) · Journal of Cell Science · doi:10.1242/jcs.143750 · Cited by 30
Quantifying Prefibrillar Amyloids in vitro by Using a “Thioflavin‐Like” Spectroscopic Method
Reinke, A. A., Abulwerdi, G. A., & Gestwicki, J. E. (2010) · ChemBioChem · doi:10.1002/cbic.201000358 · Cited by 30
Dopamine release in prefrontal cortex in response to β-amyloid activation of α7∗ nicotinic receptors
Wu, J., Khan, G. M., & Nichols, R. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.079 · Cited by 30
Lei, Y., Yang, L., Ye, C. Y., Qin, M. Y., Yang, H. Y., Jiang, H. L., Tang, X. C., & Zhang, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128366 · Cited by 30
Probing Amyloid-Beta Fibril Stability by Increasing Ionic Strengths
Zidar, J., & Merzel, F. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp109025b · Cited by 30
Hoos, M. D., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m603494200 · Cited by 30
Metadata
- Authors
- Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- LaDu, Mary Jo
- ORCID
- LaDu, Mary Jo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11612-11622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2133631618
- Cited by
- 1,015
- References
- 74
- Citations by year
- 2026: 40 · 2025: 39 · 2024: 37 · 2023: 39 · 2022: 34 · 2021: 49 · 2020: 37 · 2019: 40 · 2018: 33 · 2017: 46 · 2016: 49 · 2015: 42 · 2014: 60 · 2013: 52 · 2012: 69
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Northwestern University
- National Institutes of Health (1p01ag015501-01, 5r01ag013496-05)
- National Institute on Aging (R01AG019121, AG-15501, AG 19121, AG13496)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid-beta 42, oligomerization, fibril formation, Alzheimer's disease, neurotoxicity, peptide aggregation, solution conditions, familial Alzheimer's disease mutations, amyloid plaques, peptide conformation
- MeSH terms
- Biopolymers, Circular Dichroism, Electrophoresis, Polyacrylamide Gel, Peptide Fragments, Solubility, Blotting, Western, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review